Image source: Cresilon

Cresilon has raised $25M in a series A funding round. The company is into manufacturing and development of various medical products one of which is a revolutionary hemostatic gel that stops bleeding during a surgical procedure.

Cresilon is led by co-founder & CEO Joe Landolina, and has its headquarters in New York, USA.

Leave a Reply

Your email address will not be published. Required fields are marked *